Company Directory / research

PrivateFor profitresearchGhent, Belgium
Dualyx engages in the discovery and development of biologicals for the treatment of autoimmune and rare diseases.
Size
11-50 people: larger than 33% of companies with a size listed
Age
5 years old.
Reach
Website ranked #6,692,641 in the world for traffic, about 1k visits a month.
BiotechnologyHealth CareMedical
Funding, as listed
$43M currency not stated
What the source datasets report. We have not watched these rounds ourselves.
Everything the source datasets list about Dualyx, field by field. Contact details are held but never shown.
The company
Where
Size and reach
Funding, as listed
About this record
Growth, as the source summarises it
Dualyx may be growing as it has successfully raised 40 million euros to progress Treg therapies, which indicates a significant influx of capital to support its research and development efforts. Additionally, the company has been highlighted as a success story by BGV, suggesting a positive track record and recognition in the biotechnology investment community. This financial backing and acknowledgment from investors are indicative of a company that is expanding its operations and solidifying its presence in the biotech industry.
Summaries written by the source dataset, not by us, and not checked.
research in Belgium.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 36,920 companies in Belgium and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.